The landscape of aging

Y Cai, W Song, J Li, Y Jing, C Liang, L Zhang… - Science China Life …, 2022 - Springer
Aging is characterized by a progressive deterioration of physiological integrity, leading to
impaired functional ability and ultimately increased susceptibility to death. It is a major risk …

Heart failure in type 2 diabetes mellitus: impact of glucose-lowering agents, heart failure therapies, and novel therapeutic strategies

HC Kenny, ED Abel - Circulation research, 2019 - Am Heart Assoc
Patients with diabetes mellitus have> 2× the risk for developing heart failure (HF; HF with
reduced ejection fraction and HF with preserved ejection fraction). Cardiovascular …

New insights in cardiac β-adrenergic signaling during heart failure and aging

C Lucia, A Eguchi, WJ Koch - Frontiers in pharmacology, 2018 - frontiersin.org
Heart failure (HF) has become increasingly common within the elderly population,
decreasing their survival and overall quality of life. In fact, despite the improvements in …

Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential

TG Martin, MA Juarros, LA Leinwand - Nature Reviews Cardiology, 2023 - nature.com
Left ventricular hypertrophy is a leading risk factor for cardiovascular morbidity and mortality.
Although reverse ventricular remodelling was long thought to be irreversible, evidence from …

Fasting-mimicking diet prevents high-fat diet effect on cardiometabolic risk and lifespan

A Mishra, H Mirzaei, N Guidi, M Vinciguerra… - Nature …, 2021 - nature.com
Diet-induced obesity is a major risk factor for metabolic syndrome, diabetes and
cardiovascular disease. Here, we show that a 5-d fasting-mimicking diet (FMD) …

Therapeutic Manipulation of Myocardial Metabolism: JACC State-of-the-Art Review

H Honka, C Solis-Herrera, C Triplitt, L Norton… - Journal of the American …, 2021 - jacc.org
The mechanisms responsible for the positive and unexpected cardiovascular effects of
sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in …

Cardiac aging: from basic research to therapeutics

M Yan, S Sun, K Xu, X Huang, L Dou… - Oxidative medicine …, 2021 - Wiley Online Library
With research progress on longevity, we have gradually recognized that cardiac aging
causes changes in heart structure and function, including progressive myocardial …

Animal models of dysregulated cardiac metabolism

H Bugger, NJ Byrne, ED Abel - Circulation research, 2022 - Am Heart Assoc
As a muscular pump that contracts incessantly throughout life, the heart must constantly
generate cellular energy to support contractile function and fuel ionic pumps to maintain …

Impaired exercise tolerance in heart failure: role of skeletal muscle morphology and function

WJ Tucker, MJ Haykowsky, Y Seo, E Stehling… - Current heart failure …, 2018 - Springer
Abstract Purpose of Review To discuss the impact of deleterious changes in skeletal muscle
morphology and function on exercise intolerance in patients with heart failure with reduced …

tRNA-derived small RNAs and their potential roles in cardiac hypertrophy

J Cao, DB Cowan, DZ Wang - Frontiers in Pharmacology, 2020 - frontiersin.org
Transfer RNAs (tRNAs) are abundantly expressed, small non-coding RNAs that have long
been recognized as essential components of the protein translation machinery. The tRNA …